Is Mezzion PharmaLtd (KOSDAQ:140410) A Risky Investment?
Feb 06
Have your own idea? Try our Stock Screener
South Korean (KOSPI) Pharma Industry Analysis
UpdatedFeb 14, 2026
DataAggregated Company Financials
Companies106
- 7D4.5%
- 3M20.7%
- 1Y47.0%
- YTD20.8%
The Pharma industry is up 4.5% in the last week, with Sam Chun Dang Pharm up 7.0%. This takes the industry's 12 month performance to a gain of 47%. As for the next few years, earnings are expected to grow by 37% per annum.
Industry Valuation and Performance
Has the South Korean Pharma Industry valuation changed over the past few years?
| Date | Market Cap | Revenue | Earnings | PE | Absolute PE | PS |
|---|---|---|---|---|---|---|
| Sat, 14 Feb 2026 | ₩84.8t | ₩31.4t | ₩1.2t | 16x | 71.6x | 2.7x |
| Mon, 12 Jan 2026 | ₩71.5t | ₩31.4t | ₩1.2t | 16.3x | 60.3x | 2.3x |
| Wed, 10 Dec 2025 | ₩72.6t | ₩31.4t | ₩1.2t | 15x | 61.4x | 2.3x |
| Fri, 07 Nov 2025 | ₩68.1t | ₩31.4t | ₩1.1t | 18.7x | 64.9x | 2.2x |
| Sun, 05 Oct 2025 | ₩64.4t | ₩31.3t | ₩1.0t | 20.3x | 64.1x | 2.1x |
| Tue, 02 Sep 2025 | ₩57.8t | ₩31.1t | ₩928.8b | 18.9x | 62.2x | 1.9x |
| Thu, 31 Jul 2025 | ₩58.7t | ₩30.4t | ₩918.0b | 17.6x | 63.9x | 1.9x |
| Sat, 28 Jun 2025 | ₩53.0t | ₩30.2t | ₩914.7b | 16.1x | 58x | 1.8x |
| Mon, 26 May 2025 | ₩52.7t | ₩29.8t | ₩938.3b | 19.4x | 56.1x | 1.8x |
| Wed, 23 Apr 2025 | ₩52.7t | ₩29.6t | ₩984.4b | 17.8x | 53.6x | 1.8x |
| Fri, 21 Mar 2025 | ₩54.4t | ₩29.6t | ₩925.3b | 14.2x | 58.8x | 1.8x |
| Sun, 16 Feb 2025 | ₩56.2t | ₩29.5t | ₩1.0t | 11.7x | 56x | 1.9x |
| Tue, 14 Jan 2025 | ₩57.4t | ₩29.6t | ₩1.0t | 13.3x | 56.6x | 1.9x |
| Thu, 12 Dec 2024 | ₩50.6t | ₩29.4t | ₩988.7b | 11.8x | 51.2x | 1.7x |
| Sat, 09 Nov 2024 | ₩58.1t | ₩28.7t | ₩841.1b | 15x | 69.1x | 2x |
| Mon, 07 Oct 2024 | ₩60.0t | ₩28.7t | ₩833.2b | 15.2x | 72x | 2.1x |
| Wed, 04 Sep 2024 | ₩60.4t | ₩28.8t | ₩837.9b | 15.6x | 72.1x | 2.1x |
| Fri, 02 Aug 2024 | ₩55.5t | ₩28.4t | ₩762.2b | 14.3x | 72.8x | 2x |
| Sun, 30 Jun 2024 | ₩51.9t | ₩30.0t | ₩904.2b | 13.2x | 57.4x | 1.7x |
| Tue, 28 May 2024 | ₩52.1t | ₩30.1t | ₩897.6b | 14.7x | 58.1x | 1.7x |
| Thu, 25 Apr 2024 | ₩51.5t | ₩29.4t | ₩922.9b | 16.6x | 55.8x | 1.8x |
| Sat, 23 Mar 2024 | ₩55.5t | ₩29.9t | ₩798.2b | 21.4x | 69.5x | 1.9x |
| Mon, 19 Feb 2024 | ₩51.7t | ₩29.6t | ₩593.1b | 21x | 87.2x | 1.8x |
| Wed, 17 Jan 2024 | ₩53.8t | ₩29.6t | ₩588.5b | 23.3x | 91.5x | 1.8x |
| Fri, 15 Dec 2023 | ₩50.3t | ₩29.6t | ₩588.2b | 21.3x | 85.5x | 1.7x |
| Sun, 12 Nov 2023 | ₩48.3t | ₩29.3t | ₩683.4b | 16.7x | 70.7x | 1.6x |
| Tue, 10 Oct 2023 | ₩51.0t | ₩29.3t | ₩683.3b | 17x | 74.7x | 1.7x |
| Thu, 07 Sep 2023 | ₩50.6t | ₩29.3t | ₩683.9b | 16.2x | 74x | 1.7x |
| Sat, 05 Aug 2023 | ₩51.8t | ₩28.8t | ₩884.1b | 22.2x | 58.6x | 1.8x |
| Mon, 03 Jul 2023 | ₩47.5t | ₩28.8t | ₩899.2b | 20.5x | 52.9x | 1.6x |
| Wed, 31 May 2023 | ₩47.6t | ₩28.9t | ₩903.1b | 23x | 52.8x | 1.6x |
| Fri, 28 Apr 2023 | ₩47.3t | ₩28.5t | ₩602.7b | 20.9x | 78.5x | 1.7x |
| Sun, 26 Mar 2023 | ₩44.1t | ₩28.2t | ₩652.0b | 19.2x | 67.6x | 1.6x |
| Tue, 21 Feb 2023 | ₩45.7t | ₩27.7t | ₩743.5b | 20.7x | 61.5x | 1.6x |
Price to Earnings Ratio
61.5x
Current Industry PE
- Investors are optimistic on the South Korean Pharmaceuticals industry, and appear confident in long term growth rates.
- The industry is trading at a PE ratio of 71.6x which is higher than its 3-year average PE of 65.4x.
- The 3-year average PS ratio of 1.9x is lower than the industry's current PS ratio of 2.7x.
Past Earnings Growth
- The earnings for companies in the Pharmaceuticals industry have grown 17% per year over the last three years.
- Revenues for these companies have grown 4.3% per year.
- This means that more sales are being generated by these companies overall, and subsequently their profits are increasing too.
Industry Trends
Which industries have driven the changes within the South Korean Healthcare industry?
| KR Market | 7.56% | |
| Healthcare | 4.14% | |
| Pharma | 4.49% | |
| Pharma | 4.49% | |
Industry PEThere are no additional sub-industries under this industry.
Forecasted GrowthThere are no additional sub-industries under this industry.
Top Stock Gainers and Losers
Which companies have driven the market over the last 7 days?
| Company | Last Price | 7D | 1Y | Valuation | |
|---|---|---|---|---|---|
| A000250 Sam Chun Dang Pharm | ₩535.00k | 7.0% +₩814.0b | 205.4% | PS56.4x | |
| A128940 Hanmi Pharm | ₩601.00k | 8.9% +₩621.3b | 130.7% | PE65.4x | |
| A000100 Yuhan | ₩108.80k | 3.8% +₩297.8b | -13.0% | PE120.8x | |
| A009420 Hanall Biopharma | ₩54.50k | 11.7% +₩289.4b | 40.5% | PE1197.9x | |
| A214370 Caregen | ₩120.80k | 4.9% +₩273.7b | 319.4% | PE207.5x |
